Bausch Health Companies (BHC) Other Working Capital Changes (2009 - 2026)
Bausch Health Companies (BHC) reported Other Working Capital Changes of $1.4 million for Q1 2011, up 375.48% on a YoY basis from $302431.9 in Q1 2010, and up 907.87% sequentially from -$178000.0 in Q4 2010.
Bausch Health Companies (BHC) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 3 years of Other Working Capital Changes data on file, last reported at $1.4 million in Q1 2011.
- For the quarter ending Q1 2011, Other Working Capital Changes rose 375.48% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2011 stood at $760000.0 (up 212.43% YoY), and the FY2010 full-year result was -$1.2 million, down 577.97% from the prior year.
- Other Working Capital Changes rose to $1.4 million in Q1 2011, from -$178000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $148.0 million in Q4 2023 to a low of -$121.0 million in Q1 2024.
- A 5-year average of $10.6 million and a median of $15.0 million in 2022 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes tumbled 288.76% in 2010 and soared 375.48% in 2011, its largest moves.
- Tracing BHC's Other Working Capital Changes over 3 years: stood at -$257000.0 in 2009, then jumped by 30.74% to -$178000.0 in 2010, then soared by 907.87% to $1.4 million in 2011.
- Business Quant data shows BHC's Other Working Capital Changes at $1.4 million in Q1 2011, -$178000.0 in Q4 2010, and -$346000.0 in Q3 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.00 Mn |
| Mar 31, 2026 | 27.00 Mn |
| Mar 31, 2026 | 27.00 Mn |
| Dec 31, 2025 | -32.00 Mn |
| Dec 31, 2025 | -32.00 Mn |
| Dec 31, 2025 | -32.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | -12.00 Mn |
| Jun 30, 2025 | -12.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Mar 31, 2025 | 46.00 Mn |
| Dec 31, 2024 | -13.00 Mn |
| Dec 31, 2024 | -13.00 Mn |
| Dec 31, 2024 | -13.00 Mn |
| Sep 30, 2024 | -1.00 Mn |
| Sep 30, 2024 | -1.00 Mn |